LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The Company has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.
종목 코드 LNSR
회사 이름LENSAR Inc
상장일Sep 21, 2020
CEOCurtis (Nicholas T)
직원 수140
유형Ordinary Share
회계 연도 종료Sep 21
주소2800 Discovery Drive
도시ORLANDO
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호32826
전화18885367271
웹사이트https://www.lensar.com/
종목 코드 LNSR
상장일Sep 21, 2020
CEOCurtis (Nicholas T)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음